Moderna is slated to file a request for authorization of its two-dose vaccine for kids under 5 by the end of April, a company spokesperson told the news outlet. Pfizer is expected to have clinical trial results for its three-dose vaccine ready to share with the FDA by early May, according to the report.
The FDA has asked its outside panel of vaccine experts to reserve time for a meeting to review the pediatric vaccines as soon as June 1, sources familiar with the matter told ABC News.
In an April 21 interview with CNN+, Anthony Fauci, MD, said regulators may authorize Moderna and Pfizer’s vaccines at the same time to avoid confusion among the general public. Dr. Fauci, director of the National Institute of Allergy and Infectious Diseases, also confirmed the June timeline for the vaccines.
View the full report here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
